[18F]F-AraG PET显像在无恶性肿瘤个体中的免疫代谢活性特征
结果显示,部分参与者出现棕色脂肪激活、椎体骨髓摄取增高及植入物周围不对称摄取等多样化免疫代谢活动,提示全身[18F]F-AraG PET可反映可能影响癌症及治疗结局的系统性过程。
要点
- 无恶性肿瘤个体中[18F]F-AraG PET可见棕色脂肪激活、骨髓及肺/淋巴结摄取等多样免疫代谢活动。
- 3名服用潜在棕色脂肪激活药物的参与者出现双侧棕色脂肪激活,未经历冷暴露或禁食。
- 1名参与者椎体骨髓摄取增高,该征象此前与免疫检查点抑制剂治疗的肺癌患者生存差相关。
核心结论
- 全身[18F]F-AraG PET可捕捉无恶性肿瘤个体中多样的免疫代谢活动,反映可能影响癌症及治疗结局的系统性过程。
主要发现
- 3名服用潜在棕色脂肪激活药物的参与者出现双侧棕色脂肪激活,且无冷暴露或禁食。
- 1名参与者椎体骨髓摄取增高,该征象此前与免疫检查点抑制剂治疗的肺癌患者生存差相关。
- 2名有乳房植入物的参与者中1名出现植入物周围不对称摄取。
- 部分参与者出现后部肺摄取,常伴有既往呼吸系统疾病和胸部淋巴结摄取。
临床怎么用
- 解读[18F]F-AraG PET时需考虑无恶性肿瘤个体中棕色脂肪激活、骨髓及肺/淋巴结摄取等生理或炎症相关免疫代谢活动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
[18F]F-AraG is a clinical-stage PET tracer in immuno-oncology that accumulates in activated T cells and tissues with high mitochondrial biogenesis. Characterizing its distribution in individuals without malignancy is essential for interpreting immunometabolic states relevant to cancer biology. Methods: Twenty adults without active malignancy underwent a single [18F]F-AraG PET/CT scan, with tracer uptake assessed in relation to clinical history, medications, and demographic and physiologic factors. Results: Bilateral brown adipose tissue activation was identified in 3 participants receiving potentially brown adipose tissue-activating medications, in the absence of cold exposure or fasting. One showed elevated vertebral bone marrow uptake, previously linked to poor survival in immune checkpoint inhibitor-treated lung cancer. One of 2 participants with breast implants showed asymmetric periimplant uptake. Posterior pulmonary uptake occurred in a subset of participants, often with prior respiratory conditions and thoracic lymph node uptake. Conclusion: Whole-body [18F]F-AraG PET captures diverse immunometabolic activity in individuals without malignancy, reflecting systemic processes that may influence cancer and treatment outcomes.
引用
- Chae HD, Nobashi TW, Shrestha U, et al. [18F]F-AraG PET Imaging of Immunometabolic Activity in Individuals Without Malignancy. J Nucl Med. 2026. PMID: 42880964. doi:10.2967/jnumed.126.273076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。